Valuation: Yunnan Botanee Bio-Technology Group Co.LTD

Market Cap 1.33TCr 196.22Cr 171.48Cr 158.23Cr 145.85Cr 274.9Cr 19TCr 281.01Cr 1.89TCr 743.89Cr 9.25TCr 736.91Cr 720.74Cr 32TCr P/E 2026 *
20.8x
P/E 2027 * 18x
Enterprise Value 1.16TCr 171.87Cr 150.19Cr 138.59Cr 127.75Cr 240.79Cr 17TCr 246.13Cr 1.66TCr 651.56Cr 8.11TCr 645.44Cr 631.28Cr 28TCr EV / Sales 2026 *
1.92x
EV / Sales 2027 * 1.74x
Free-Float
50.21%
Yield 2026 *
2.36%
Yield 2027 * 2.49%
01/07 Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on April 29, 2026. CI
22/05 Yunnan Botanee Bio-Technology Group Co.LTD Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2025, Payable on 28 May 2026 CI
29/04 Yunnan Botanee Bio-Technology Group Co.LTD announces an Equity Buyback for CNY 200 million worth of its shares. CI
28/04 Jefferies Adjusts Yunnan Botanee Bio-Technology's Price Target to 40 Yuan from 42 Yuan, Keeps at Hold MT
26/04 Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
23/04 Yunnan Botanee Bio-Technology Group Co.LTD authorizes a Buyback Plan. CI
03/03 Yunnan Botanee Bio-Technology Group Co.LTD Approves Cash Dividend on A Shares for the Third Quarter of 2025, Payable on 10 March 2026 CI
12/02 Yunnan Botanee Bio-Technology Group Co.Ltd Proposes Dividend for the Third Quarter of 2025 CI
12/01 Yunnan Botanee Bio-Technology Group's shareholder plans to cut stake RE
10/12 Suzhou Zisong Medical Technology Co., Ltd announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD, Beijing Zhongguancun Qihang Venture Capital and other investors CI
27/25/27 Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
29/25/29 Macquarie Downgrades Yunnan Botanee Bio-Technology Group to Underperform from Outperform; Price Target is 42 Yuan MT
27/25/27 Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Half Year Ended June 30, 2025 CI
1 day-4.48%
1 week-0.41%
Current month+0.19%
1 month-5.14%
3 months-14.17%
6 months-24.99%
Current year-20.30%
1 week 30.66
Extreme 30.66
33.5
1 month 29.48
Extreme 29.48
33.57
Current year 29.48
Extreme 29.48
49.79
1 year 29.48
Extreme 29.48
51.8
3 years 29.48
Extreme 29.48
109.3
5 years 29.48
Extreme 29.48
272.72
10 years 29.48
Extreme 29.48
289.35
Manager TitleAgeSince
Chief Executive Officer 63 01/12/2016
Director of Finance/CFO 44 06/03/2019
Corporate Officer/Principal 47 28/02/2023
Director TitleAgeSince
Chairman 63 01/06/2014
Director/Board Member 50 01/11/2012
Director/Board Member 44 01/06/2014
Change 5-day change 1-year change 3-year change Capi.($)
-4.48%-0.41%-28.61%-64.63% 196.22Cr
+0.10%+0.20%+5.30%-6.51% 23TCr
+1.53%-0.20%+35.51% - 5.02TCr
+1.95%+4.80%+131.18% - 989.45Cr
+1.19%+11.07%+27.18%-50.98% 753.03Cr
+2.98%+1.06%-8.26%+17.80% 517.11Cr
-1.07%-3.99%-37.35%-38.34% 434.31Cr
+0.42%+3.31%-4.84%-9.46% 394.65Cr
-5.80%-1.72%-30.51%-48.97% 328.27Cr
-1.28%+1.87%-18.28%-47.37% 263.27Cr
Average -0.45%+2.12%+7.13%-31.06% 3.22TCr
Weighted average by Cap. +0.34%+0.56%+12.70%-9.26%

Financials

2026 *2027 *
Net sales 606.43Cr 89Cr 78Cr 72Cr 67Cr 125.34Cr 8.62TCr 128.13Cr 862.35Cr 339.18Cr 4.22TCr 336Cr 328.62Cr 15TCr 665.4Cr 98Cr 86Cr 79Cr 73Cr 137.53Cr 9.45TCr 140.59Cr 946.2Cr 372.16Cr 4.63TCr 368.67Cr 360.58Cr 16TCr
Net income 64Cr 9.47Cr 8.27Cr 7.63Cr 7.04Cr 13Cr 911.73Cr 14Cr 91Cr 36Cr 446.53Cr 36Cr 35Cr 1.54TCr 74Cr 11Cr 9.55Cr 8.81Cr 8.12Cr 15Cr 1.05TCr 16Cr 105.28Cr 41Cr 515.18Cr 41Cr 40Cr 1.77TCr
Net Debt -165.08Cr -24Cr -21Cr -20Cr -18Cr -34Cr -2.35TCr -35Cr -234.74Cr -92Cr -1.15TCr -91Cr -89Cr -3.95TCr -173.67Cr -26Cr -22Cr -21Cr -19Cr -36Cr -2.47TCr -37Cr -246.96Cr -97Cr -1.21TCr -96Cr -94Cr -4.16TCr
Logo Yunnan Botanee Bio-Technology Group Co.LTD
Yunnan Botanee Bio-Technology Group Co Ltd is a China-based company mainly engaged in the production of cosmetics. The Company's products mainly include creams, skin care lotions, facial masks, essences, lotions and other skin care products and make-up products such as isolation creams, blemish balm (BB) creams, and makeup removers. The Company is also engaged in the research and development, production and sales of skin care-related medical device products, mainly including hyaluronic acid repairing biofilm, hyaluronic acid repairing dressings, mainly used for the protection of skin with damaged barriers after minimally invasive surgery and care. The Company primarily operates in the domestic market.
Employees
3,574
Date Price Change Volume
17/26/17 CN¥31.57 -4.48% 1,02,83,611
16/26/16 CN¥33.05 +1.79% 1,00,73,000
15/26/15 CN¥32.47 +4.74% 1,02,55,693
14/26/14 CN¥31.00 +0.29% 49,90,404
13/26/13 CN¥30.91 -2.49% 48,30,479
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
31.57CNY
Average target price
44.54CNY
Spread / Average Target
+41.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300957 Stock